The White House released a health care plan Jan. 15 addressing drug prices, health insurance premiums and price transparency efforts. The plan includes codifying the administration’s “most favored nation” agreements recently reached with certain drugmakers, where companies must offer Americans the lowest cost paid for the same medications in other countries. It also calls for sending subsidies directly to Americans instead of insurance companies and funding cost-sharing reductions to reduce premiums. The plan would also require health insurers to publish rate and coverage comparisons on their websites “in plain English — not industry jargon” for consumers. In addition, the plan calls for any health provider or insurer accepting Medicare or Medicaid to “prominently” post their pricing and fees. 

Headline
The Centers for Medicare & Medicaid Services July 16 released draft guidance for the 2028 cycle of negotiations under the Medicare Drug Price Negotiation…
Headline
The AHA provided a statement to the House Ways and Means Committee for a markup July 15 on various pieces of health legislation. The AHA offered…
Headline
Health Insurance Marketplace insurers will propose a median premium increase of 14% for 2027, according to an analysis of preliminary rate filings published…
Blog
Public
Making healthcare more affordable for families, businesses, and the federal and state governments is an important goal. High-quality healthcare should support…
Headline
A blog by Noah Isserman, AHA director of health insurance and coverage policy, explains why a recent analysis by the Medicare Payment Advisory Commission…
Headline
The Food and Drug Administration June 22 announced multiple actions to help accelerate early- and late-stage drug development. The actions are part of a larger…